Today: October 16, 2018, 12:16 am
  
Health

Sponsors Recommend Novotech for CRO Leadership Award

Sponsors Recommend Novotech for CRO Leadership Award
PR-Inside.com: 2018-08-09 16:28:44
SYDNEY, Aug 9, 2018 - (ACN Newswire) - Asia-Pacific specialist CRO Novotech has been awarded the "Exceeded Customer Expectations" Award by Life Science Leader magazine based on findings from sponsor companies that utilise outsourcing services. In particular, Novotech was recognised for its local market/regulatory knowledge and for meeting timelines. www.croleadershipawards.com/


As part of a 2018 review of the CRO industry from the biopharma perspective, Life Science Leader selected Novotech as a leader in a number of key categories including:

- Local market/regulatory knowledge

- Operational Excellence

- Scientific knowledge

- Therapeutic experience

- Study design expertise

- Responsiveness

- Data quality

- Meeting overall project timelines

According to Life Science Leader:

"The vetting process for selecting outsourcing partners is time consuming and complex.

To support the process, Life Science Leader developed the CRO Leadership Awards in 2012.

We think sponsor company opinions are important and credible - that's why the awards are based on customer feedback.

Winning CROs are chosen through impartial market research based on feedback from sponsor companies that utilize outsourcing services.

Primary market research by Industry Standard Research (ISR) is the basis of the awards.

Sponsors provide ratings of CROs based on recent outsourced projects. This experiential feedback is analyzed by sponsor company size to reveal leading CROs in different performance categories."

Novotech CEO Dr John Moller said he was pleased Novotech was recognised by the industry for its expertise, especially for Asia-Pacific local market/regulatory knowledge.

"Novotech, known as the Asia-Pacific CRO, has offices and teams on the ground as well as MOUs and long-term relationships with major hospitals that directly benefit our clients."

"Our in-country relationships enable a more comprehensive understanding of local regulatory changes, access to leading PIs, strong site connections, and productive patient populations to deliver success for our clients within timelines and budgets."

Novotech was established in 1996, headquartered in Australia with offices in 11 countries across the region, and MOUs with major health providers.

About Novotech - novotech-cro.com/welcome

Headquartered in Sydney, Novotech is internationally recognised as the leading regional full-service contract research organisation (CRO). With a focus on clinical monitoring, Novotech has been instrumental in the success of hundreds of Phase I - IV clinical trials in the Asia Pacific region.

Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, project and vendor management. Novotech's strong Asia Pacific presence includes running clinical trials in all key regional markets. Novotech also has worldwide reach through the company's network of strategic partners.

For RFP enquiries: Please fill out the form available at www.novotech-cro.com/contact-us-0

Media Contact

Susan Fitzpatrick-Napier, communications@novotech-cro.com, AU: +61 2 8218 2144, USA: +1 415 951 3228, Asia: +65 3159 3427

Press Information


Published by
ACN Newswire
+65 6304 8926
e-mail
www.acnnewswire.com



# 471 Words
Related Articles
More From The Author
Watts Miners Reports Sales Figure over $80 [..]
Watts Miners, the latest big name to enter the crypto mining space, has received an encouraging response from the cryptocurrency [..]
Trillium Challenges World's Top Hackers to "Pass [..]
Invites hackers to attack cybersecurity platform during Black Hat 2018 / DEFCON26 Las Vegas-DEFCON, Aug 8, 2018 - (ACN Newswire) [..]
Coalition to Protect OKD Miners Protests Zdenek [..]
The Coalition has launched protests at controversial Czech billionaire's residence to hold him accountable for perpetrating what [..]
IOTW Announces Strategic Partnerships with Consta Mobile [..]
HONG KONG, Aug 6, 2018 - (ACN Newswire) - AnApp Blockchain Technologies Limited ("AnApp"), the IOTW blockchain developer, [..]
'SORACOM with KDDI', Partnering with KDDI Overseas [..]
Starting IoT business from Southeast Asia and the U.S. TOKYO, Aug 3, 2018 - (JCN Newswire) - KDDI CORPORATION and [..]
 
More From Health
NSAV SUBSIDIARY SIGNS MAJOR AGREEMENT WITH ELI [..]
Net Savings Link, Inc. (OTC: NSAV), a medical technology and software company, announced today that its subsidiary, Shanghai based [..]
NSAV ANNOUNCES AGREEMENT TO ACQUIRE MAJOR STAKE [..]
Net Savings Link, Inc. (OTC: NSAV), a medical technology and software company, announced today that the Company has acquired a [..]
Drug Abuse Treatment Market to Surpass US$ [..]
(EMAILWIRE.COM, August 06, 2018 ) Global Drug Abuse Treatment Market, by Abuse Type (Alcohol Dependence, Tobacco/Nicotine Addiction, [..]
Nurse Staffing Agency Website Focuses on Services; [..]
Elkhart, IN; August 1, 2018 – Excellent Nursing Services, Inc. (ENS) has announced the launch of the agency’s website highlighting [..]
Primary Sclerosing Cholangitis Market to Reach US$ [..]
(EMAILWIRE.COM, July 30, 2018 ) Global Primary Sclerosing Cholangitis Market, by Drug (BT1023, GS-9674, NGM282, OCA, LUM001, and [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.